Decentralizing Clinical Research at Scale
Cloud-based SaaS for rapid remote touch-less recruitment and electronic informed consent with frictionless user experience
We interviewed hundreds of stakeholders of clinical research.
They all expressed dissatisfaction and complained about the poor experience with clinical trials. Whether you are working with a patient group that is setting up a registry or natural history study, or with biotech that is sponsoring a long-term follow-up study for gene therapy, Jeeva Clinical can save you time and money while improving recruitment and retention of trial participants.
Reduces the logistical burden on study teams and participants by 70 percent
With bi-directional communications, scheduling, eligibility screening, and remote touch-less electronic informed consent, investigators can rapidly enroll participants in clinical studies with participants safely reviewing the study material at their own convenience remotely from their own mobile device.
Packages that fit the budgets of research investigators or quality needs of global multi-site studies
We understand technology is a means to an end. We strive to achieve the right balance between the use of technology and expert human intervention to optimize trial operations. Clinical study teams spend hundreds of hours coordinating participants' schedules to ensure quality and compliance.
Reduces the timelines for study startup and participants recruitment by 58%
Jeeva SaaS streamlines the workflows for eligibility screening, bi-directional communications, and remote electronic informed consents with a focus on accelerating timelines while improving the user experience. We focus on optimizing the study operations so you can focus on research outcomes.
Registries and Natural History Studies
Longitudinal cohort studies collect clinical, behavioral, lifestyle, and environmental data from participants in real-world settings over extended periods of time. Our bring-your-own-device platform makes it easy for study investigators to onboard, engage, and retain participants. The FDA and NIH's National Center for Advanced Translational Sciences have encouraged patient groups to drive establishment of high-quality institutional review board approved patient registries and natural history studies.
Long-Term Follow Up Studies
Cell and gene therapy trials typically involve one-time therapy administration with long-term follow up with patients for safety monitoring. Physical site visit requirements over a long period of time places undue burden on trial participants. Jeeva simplifies this process by fitting the trial into the lifestyle of patients. Cell and gene therapies are the most advanced form of one-and-done treatments for patients with rare genetic diseases including cancer. FDA guidelines in January 2020 require sponsors of such therapy trials to monitor patients over extended periods of time to better understand the durability of these treatments. Most of the existing clinical trials management or electronic data capture tools were designed for traditional brick and mortar clinical trials that usually span less than three years. Our purpose-designed solution for five, 10, or 15-year follow up studies is the perfect solution for these studies.
Investigator Initiated Trials
Our experienced coordinators provide the highest quality of video conferencing visits for patients and caregivers. Our goal is to help simplify and manage the trial operations to minimize burden, reduce dropouts, improve compliance, and accelerate the development of therapies. Investigator initiated single site studies suffer from lack of funding necessary to conduct certain large-scale, real-world evidence, observational, or drug repurposing studies of medicines already proven safe. Jeeva SaaS platform offers a cost-effective solution to quickly setup and conduct clinical studies of any scale or duration, with or without patient travel involved.